Pfizer Covid pill
Pfizer to allow other drug manufacturers to make its Covid pill, 95 nations to benefit
Geneva/IBNS: US pharmaceutical major Pfizer has announced plans to make its antiviral pill against COVID-19 available to other drug manufacturers so as to benefit the world's least wealthy countries.
Pfizer will sub-licence production of its Paxlovid pill to generic drug manufacturers for supply in 95 low and middle-income nations, media reports said.
This will cover around 53 percent of the world's population.
As a part of the deal struck with the global Medicines Patent Pool (MPP), Pfizer will not receive royalties from the generic manufacturers, making the treatment much cheaper.
The agreement is subject to the oral antiviral medication passing ongoing trials and regulatory approval.
The Pfizer drug is to be taken with the HIV medicine ritonavir, said reports.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
